Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.
about
Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.Drug-Bearing Supramolecular Filament Hydrogels as Anti-Inflammatory AgentsSelf-assembled micelles based on pH-sensitive PAE-g-MPEG-cholesterol block copolymer for anticancer drug deliveryDiscovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery.Design and assembly of supramolecular dual-modality nanoprobesOne-component nanomedicineMembrane-active peptides from marine organisms--antimicrobials, cell-penetrating peptides and peptide toxins: applications and prospects.Strategies to release doxorubicin from doxorubicin delivery vehicles.Controlling toxicity of Peptide-drug conjugates by different chemical linker structures.Peptide-drug conjugates as effective prodrug strategies for targeted delivery.Peptide based hydrogels for cancer drug release: modulation of stiffness, drug release and proteolytic stability of hydrogels by incorporating d-amino acid residue(s).Supramolecular biofunctional materials.Nanotherapeutic systems for local treatment of brain tumors.Covalent, Non-Covalent, Encapsulated Nanodrug Regulate the Fate of Intra- and Extracellular Trafficking: Impact on Cancer and Normal Cells.Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy.Self-assembling prodrugs.Cell-penetrating peptide conjugates to enhance the antitumor effect of paclitaxel on drug-resistant lung cancer.Anticancer nanoparticulate polymer-drug conjugate.A Synthesized Glucocorticoid- Induced Leucine Zipper Peptide Inhibits Retinal Müller Cell Gliosis.
P2860
Q30355600-A5B95588-5122-4F12-B1A0-32430FA4CE83Q33836407-DB795F60-8C45-4F01-A067-30CFEB132573Q34415598-60EF3293-01BB-4DC5-BFA8-DCC5B9D001DDQ35785197-7A65313A-291A-4A0F-AEB4-CE225EACFC1EQ36024654-07F070C2-52F5-4CA0-B6E5-13037D723977Q36201042-A5BCAE65-B802-4B8A-95D9-24226E79A7A0Q36307689-67393FDA-4CEB-44DE-94C3-08C8312D582CQ38307801-7F0E9566-18B1-447B-A7EE-E54528614662Q38643071-0CD438FB-C9E4-4556-AC64-09EB546A625DQ38882129-DE69023B-3E1B-41C1-A670-C4584237E450Q38883760-437AC602-4FCC-461A-BDCD-33F72B5F266EQ38893813-E0A73AAC-66B6-45CF-AC2E-FD0244574B3FQ39188196-CCA65ED3-8498-4ACD-923E-494E1B85D481Q39330269-F2576849-3645-4B17-8907-7A96E18347D7Q41123555-DB362755-4F55-412C-B8DC-2F942BF8522CQ47621457-BA20AE13-36D8-4F78-8F41-97015594C5EEQ47904111-0851F627-4614-4E69-8323-9291CE8CAD6AQ50675888-DC5F1E3B-1C41-49A6-B814-CDF329C09AAAQ55030497-E0805CCC-BB60-4D17-9A11-9E1D843C5C0AQ55253987-5AFFA3A8-722C-45DA-9C31-01EB5A8A4A16
P2860
Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.
@en
type
label
Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.
@en
prefLabel
Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.
@en
P2093
P1476
Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.
@en
P2093
Andrew G Cheetham
Honggang Cui
Jae Hyon Moon
James W Moxley
Zhipeng Chen
P304
P356
10.1016/J.JCONREL.2014.05.051
P407
P577
2014-06-02T00:00:00Z